BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Franco MS, Gomes ER, Roque MC, Oliveira MC. Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment. Front Oncol 2021;11:623760. [PMID: 33796461 DOI: 10.3389/fonc.2021.623760] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Regenold M, Wang X, Kaneko K, Bannigan P, Allen C. Harnessing immunotherapy to enhance the systemic anti-tumor effects of thermosensitive liposomes. Drug Deliv Transl Res 2023;13:1059-73. [PMID: 36577832 DOI: 10.1007/s13346-022-01272-w] [Reference Citation Analysis]
2 Edwards IA, De Carlo F, Sitta J, Varner W, Howard CM, Claudio PP. Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers. IJMS 2023;24:5474. [DOI: 10.3390/ijms24065474] [Reference Citation Analysis]
3 Pourmadadi M, Mahdi Eshaghi M, Ostovar S, Mohammadi Z, K. Sharma R, Paiva-santos AC, Rahmani E, Rahdar A, Pandey S. Innovative nanomaterials for cancer diagnosis, imaging, and therapy: Drug deliveryapplications. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104357] [Reference Citation Analysis]
4 Maciver SK, Abdelnasir S, Anwar A, Siddiqui R, Khan NA. Modular nanotheranostic agents for protistan parasitic diseases: Magic bullets with tracers. Mol Biochem Parasitol 2023;253:111541. [PMID: 36603708 DOI: 10.1016/j.molbiopara.2022.111541] [Reference Citation Analysis]
5 Liu C, Wu K, Li J, Mu X, Gao H, Xu X. Nanoparticle-mediated therapeutic management in cholangiocarcinoma drug targeting: Current progress and future prospects. Biomed Pharmacother 2023;158:114135. [PMID: 36535198 DOI: 10.1016/j.biopha.2022.114135] [Reference Citation Analysis]
6 Sagar R, Jaremba EA, Lou J, Best MD. Copper-responsive liposomes for triggered cargo release employing a picolinamide-lipid conjugate. Org Biomol Chem 2023;21:955-9. [PMID: 36622111 DOI: 10.1039/d2ob01977a] [Reference Citation Analysis]
7 Duarte JA, Gomes ER, De Barros ALB, Leite EA. Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines. Pharmaceutics 2023;15. [PMID: 36839690 DOI: 10.3390/pharmaceutics15020369] [Reference Citation Analysis]
8 Cai W, Lv W, Meng L, Duan Y, Zhang L. The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer. Int J Nanomedicine 2023;18:339-51. [PMID: 36703724 DOI: 10.2147/IJN.S387409] [Reference Citation Analysis]
9 Priester MI, Ten Hagen TLM. Image-guided drug delivery in nanosystem-based cancer therapies. Adv Drug Deliv Rev 2023;192:114621. [PMID: 36402247 DOI: 10.1016/j.addr.2022.114621] [Reference Citation Analysis]
10 Selianitis D, Sentoukas T, Skandalis A, Balafouti A, Pippa N, Pispas S. Stimulus-responsive liposomes as smart nanocarriers for drug delivery applications. Novel Platforms for Drug Delivery Applications 2023. [DOI: 10.1016/b978-0-323-91376-8.00013-6] [Reference Citation Analysis]
11 Maswadeh HM, Khan A, Alorainy MS, Al-Wabel NA, Demetzos C. Concomitant delivery of doxorubicin and cisplatin through liposome-based thermosensitive nanoparticles: perspective in the treatment of cancer in animal models. Am J Cancer Res 2023;13:379-93. [PMID: 36895979] [Reference Citation Analysis]
12 Alshaer W, Nsairat H, Lafi Z, Hourani OM, Al-Kadash A, Esawi E, Alkilany AM. Quality by Design Approach in Liposomal Formulations: Robust Product Development. Molecules 2022;28. [PMID: 36615205 DOI: 10.3390/molecules28010010] [Reference Citation Analysis]
13 Nikolova MP, Kumar EM, Chavali MS. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment. Pharmaceutics 2022;14:2195. [PMID: 36297630 DOI: 10.3390/pharmaceutics14102195] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gomes ER, Carvalho AT, Barbosa TC, Ferreira LL, Calado HDR, Sabino AP, Oliveira MC. Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer. AAPS PharmSciTech 2022;23. [DOI: 10.1208/s12249-022-02349-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Regenold M, Wang X, Kaneko K, Bannigan P, Allen C. Harnessing Immunotherapy to Enhance the Systemic Anti-Tumor Effects of Thermosensitive Liposomes.. [DOI: 10.21203/rs.3.rs-2011275/v1] [Reference Citation Analysis]
16 Regenold M, Wang X, Kaneko K, Bannigan P, Allen C. Harnessing Immunotherapy to Enhance the Systemic Anti-Tumor Effects of Thermosensitive Liposomes.. [DOI: 10.1101/2022.08.29.505721] [Reference Citation Analysis]
17 Masuda N, Ono M, Mukohara T, Yasojima H, Shimoi T, Kobayashi K, Harano K, Mizutani M, Tanioka M, Takahashi S, Kogawa T, Suzuki T, Okumura S, Takase T, Nagai R, Semba T, Zhao Z, Ren M, Yonemori K. Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort. European Journal of Cancer 2022;168:108-18. [DOI: 10.1016/j.ejca.2022.03.004] [Reference Citation Analysis]
18 Cardoso BD, Cardoso VF, Lanceros-méndez S, Castanheira EMS. Solid Magnetoliposomes as Multi-Stimuli-Responsive Systems for Controlled Release of Doxorubicin: Assessment of Lipid Formulations. Biomedicines 2022;10:1207. [DOI: 10.3390/biomedicines10051207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Zhang H, Zhang M, Zhang X, Gao Y, Ma Y, Chen H, Wan J, Li C, Wang F, Sun X. Enhanced postoperative cancer therapy by iron-based hydrogels. Biomater Res 2022;26. [DOI: 10.1186/s40824-022-00268-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Chude-okonkwo UK. Enhancing Nanocarrier Trigger-Sensitivity for Targeted Drug Delivery Application using Ligand-Receptor Residence Time Factor. 2022 IEEE 16th International Symposium on Medical Information and Communication Technology (ISMICT) 2022. [DOI: 10.1109/ismict56646.2022.9828241] [Reference Citation Analysis]
21 García MC, Calderón-Montaño JM, Rueda M, Longhi M, Rabasco AM, López-Lázaro M, Prieto-Dapena F, González-Rodríguez ML. pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin. Int J Pharm 2022;:121691. [PMID: 35331830 DOI: 10.1016/j.ijpharm.2022.121691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Lötscher J, Martí I Líndez AA, Kirchhammer N, Cribioli E, Giordano Attianese GMP, Trefny MP, Lenz M, Rothschild SI, Strati P, Künzli M, Lotter C, Schenk SH, Dehio P, Löliger J, Litzler L, Schreiner D, Koch V, Page N, Lee D, Grählert J, Kuzmin D, Burgener AV, Merkler D, Pless M, Balmer ML, Reith W, Huwyler J, Irving M, King CG, Zippelius A, Hess C. Magnesium sensing via LFA-1 regulates CD8+ T cell effector function. Cell 2022;185:585-602.e29. [PMID: 35051368 DOI: 10.1016/j.cell.2021.12.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
23 Gomes ER, Franco MS. Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy. Pharmaceutics 2022;14:105. [PMID: 35057001 DOI: 10.3390/pharmaceutics14010105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, Brooks AE, Pullan JE, Dailey KM. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel) 2021;11:3018. [PMID: 34835785 DOI: 10.3390/nano11113018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Abadi AJ, Mirzaei S, Mahabady MK, Hashemi F, Zabolian A, Hashemi F, Raee P, Aghamiri S, Ashrafizadeh M, Aref AR, Hamblin MR, Hushmandi K, Zarrabi A, Sethi G. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res 2021. [PMID: 34697839 DOI: 10.1002/ptr.7305] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 15.5] [Reference Citation Analysis]
26 Esfahani MKM, Alavi SE, Cabot PJ, Islam N, Izake EL. PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells. Pharmaceutics 2021;13:1605. [PMID: 34683898 DOI: 10.3390/pharmaceutics13101605] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
27 Tang L, Li J, Zhao Q, Pan T, Zhong H, Wang W. Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery. Pharmaceutics 2021;13:1151. [PMID: 34452113 DOI: 10.3390/pharmaceutics13081151] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
28 Delehedde C, Even L, Midoux P, Pichon C, Perche F. Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles. Pharmaceutics 2021;13:945. [PMID: 34202584 DOI: 10.3390/pharmaceutics13070945] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]